CLINICAL TRIAL: CHILDHOOD ASTHMA MANAGEMENT PROGRAM CONTINUATION STUDY PHASE 2 (

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 这项研究的目的是进一步评估儿童早期给予长期哮喘治疗的效果。这项研究将测试在5至12岁的儿童中使用吸入皮质类固醇进行3.5至5年的哮喘治疗是否在允许最大限度地实现肺生长方面具有长期好处。这将通过继续跟进最初的儿童哮喘管理计划(CAMP)队列来实现，直到大多数人达到他们成年的最大身高。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of the study is to further assess the effects of long-term asthma treatment given early in childhood. This study will test whether 3.5 to 5 years of asthma treatment in children 5 to 12 years of age with inhaled corticosteroids has a long-term benefit in allowing maximum attainment of lung growth. This will be achieved by continued follow-up of the original Childhood Asthma Management Program (CAMP) cohort until the majority have reached their maximal adult height.